The big question is whether management finds such a procedure urgent, the analysts added. After speaking with management, Yee said that will likely depend on whether there is continued underperformance -- for example, additional periods of lowered guidance -- or if a like-minded activist surfaces.
More from Healthcare
Two food-related names and one in health care look like promising investments right now.
Time to review the charts and indicators.
As more Americans struggle with obesity, Medifast sees strength in weight-loss offerings.